Published in J Magn Reson Imaging on November 01, 2004
Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol (2009) 1.29
MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol (2005) 1.26
Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry. J Neurol Sci (2009) 1.11
Localization of grey matter atrophy in early RRMS : A longitudinal study. J Neurol (2006) 1.06
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One (2011) 1.05
Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx (2005) 0.98
Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study. J Neurol (2009) 0.92
MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J Neurol (2006) 0.91
Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS : a MRSI study. J Neurol (2007) 0.89
Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. Mult Scler (2009) 0.85
Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy. World J Gastroenterol (2009) 0.84
Multi-parametric representation of voxel-based quantitative magnetic resonance imaging. PLoS One (2014) 0.83
Prevalence of grey matter pathology in early multiple sclerosis assessed by magnetization transfer ratio imaging. PLoS One (2011) 0.81
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study. Mult Scler (2014) 0.78
Evidencing different neurochemical profiles between thalamic nuclei using high resolution 2D-PRESS semi-LASER (1)H-MRSI at 7 T. MAGMA (2016) 0.77
Localization and quantification of intramuscular damage using statistical parametric mapping and skeletal muscle parcellation. Sci Rep (2015) 0.76
Magnetization transfer imaging reveals geniculocalcarine and striate area degeneration in primary glaucoma: a preliminary study. Acta Radiol Open (2016) 0.75
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol (2007) 3.81
Do oxidative and anaerobic energy production in exercising muscle change throughout growth and maturation? J Appl Physiol (1985) (2010) 3.29
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol (2011) 3.16
Decreased basal fMRI functional connectivity in epileptogenic networks and contralateral compensatory mechanisms. Hum Brain Mapp (2009) 2.38
Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients. Arch Neurol (2012) 2.13
Natural history of multiple sclerosis with childhood onset. N Engl J Med (2007) 1.89
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler (2012) 1.77
Graph theoretical analysis of structural and functional connectivity MRI in normal and pathological brain networks. MAGMA (2010) 1.75
Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization. Arch Neurol (2004) 1.65
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol (2009) 1.51
Role of resting state functional connectivity MRI in presurgical investigation of mesial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (2010) 1.47
Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci (2005) 1.45
Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging. Eur J Cardiothorac Surg (2005) 1.41
NOS substrate during cardioplegic arrest and cold storage decreases stunning after heart transplantation in a rat model. J Heart Lung Transplant (2003) 1.39
Imaging structural and functional connectivity: towards a unified definition of human brain organization? Curr Opin Neurol (2008) 1.33
Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magn Reson Med (2005) 1.25
A benign form of neuromyelitis optica: does it exist? Arch Neurol (2011) 1.21
Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology (2009) 1.20
Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 1.18
Comparative MRI analysis of T2 changes associated with single and repeated bouts of downhill running leading to eccentric-induced muscle damage. J Appl Physiol (1985) (2008) 1.11
Reproducibility assessment of metabolic variables characterizing muscle energetics in vivo: A 31P-MRS study. Magn Reson Med (2009) 1.11
Interictal functional connectivity of human epileptic networks assessed by intracerebral EEG and BOLD signal fluctuations. PLoS One (2011) 1.09
Grid-free interactive and automated data processing for MR chemical shift imaging data. MAGMA (2009) 1.09
Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp (2003) 1.07
Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter. Mult Scler (2004) 1.07
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS. J Neurol (2013) 1.06
Magnetic resonance spectroscopy reveals an impaired brain metabolic profile in mice resistant to cerebral malaria infected with Plasmodium berghei ANKA. J Biol Chem (2007) 1.06
Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS One (2007) 1.06
In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. Int J Cancer (2011) 1.05
Structure of WM bundles constituting the working memory system in early multiple sclerosis: a quantitative DTI tractography study. Neuroimage (2007) 1.04
Perfusional deficit and the dynamics of cerebral edemas in experimental traumatic brain injury using perfusion and diffusion-weighted magnetic resonance imaging. J Neurotrauma (2007) 1.04
High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging. Magn Reson Med (2004) 1.04
The rate of PCr resynthesis is not a reliable index of skeletal muscle oxidative capacity. Eur J Appl Physiol (2013) 1.04
Assessment of white matter injury and outcome in severe brain trauma: a prospective multicenter cohort. Anesthesiology (2012) 1.03
Heterogeneity of muscle recruitment pattern during pedaling in professional road cyclists: a magnetic resonance imaging and electromyography study. Eur J Appl Physiol (2004) 1.02
(1)H MR spectroscopy of human brain tumours: a practical approach. Eur J Radiol (2008) 1.02
Functional magnetic resonance imaging and cognition at the very early stage of MS. J Neurol Sci (2006) 1.01
Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis. Mult Scler (2012) 1.00
Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg (2003) 0.99
Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp (2005) 0.99
Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid. PLoS One (2007) 0.99